Characteristics and outcomes of patients enrolled in the Connect 360 benralizumab patient support programme in the UK: a retrospective cohort study
Crossref DOI link: https://doi.org/10.1136/bmjresp-2023-001734
Published Online: 2024-01-23
Published Print: 2024-01
Update policy: https://doi.org/10.1136/crossmarkpolicy
Morris, Tamsin
Wood, Robert
Silvey, Mark
Diomatari, Christina
Lipworth, Joe
Menon, Shruti https://orcid.org/0009-0002-8392-0728
Funding for this research was provided by:
AstraZeneca, UK
License valid from 2024-01-23